D.M. Shacklady-McAtee et al. / Tetrahedron 70 (2014) 4257e4263
4261
24
1321, 1253, 1020 cmꢂ1; HRMS (EIþ) [M]þ calculated for C18H17NO:
l
¼254 nm); tR (minor)¼6.33 min, tR (major)¼6.73 min. [
a
]
D
263.1310, found: 263.1297.
ꢂ64.0 (c 0.64, CHCl3): 1H NMR (400 MHz, CDCl3)
d 7.88e7.76 (m,
3H), 7.76e7.70 (m, 1H), 7.53e7.42 (m, 3H), 7.42e7.33 (m, 2H),
7.33e7.16 (m, 3H), 5.53 (s, 1H), 5.27 (t, J¼1.3 Hz, 1H), 4.24 (q,
J¼7.0 Hz, 1H), 1.60 (d, J¼7.0 Hz, 3H); 13C NMR (101 MHz, CDCl3)
4.2.5. (S,E)-2-(4-(4-(Trifluoromethyl)phenyl)but-3-en-2-yl)naphtha-
lene (6). General procedure was followed using 3 mol % Ni(cod)2
and benzylic ammonium triflate 1a prepared in 99.6% ee. The crude
material was purified by silica gel chromatography (100% hexanes)
to give compound 6 (53.0 mg, 81%) as a white solid (mp 70e73 ꢀC).
The enantiomeric excess was determined to be 98% ee by chiral
d
152.5, 142.7, 142.2, 133.7, 132.3, 128.2, 128.2, 127.8, 127.7, 127.3,
126.8, 126.6, 125.9, 125.4, 113.5, 44.4, 21.8; 13C NMR (101 MHz,
(CD3)2CO) 152.6, 142.8, 142.1, 133.7, 132.2, 128.0, 127.9, 127.53,
d
127.46, 127.2, 126.6, 126.4, 125.82, 125.79, 125.3, 112.5, 43.7, 21.2;
FTIR (NaCl/thin film) 3053, 2967, 2930, 2361, 2337, 1624, 1599,
1506 cmꢂ1; HRMS (EIþ) [M]þ calculated for C20H18: 258.1409,
found: 258.1422. Please note: Although two 13C NMR peaks are
coincident when CDCl3 is used as solvent, all 18 13C NMR peaks are
seen when (CD3)2CO is used as solvent.
HPLC analysis (CHIRALPAK IB, 0.8 mL/min, 100% hexane,
24
l
¼254 nm); tR (major)¼24.21 min, tR (minor)¼30.68 min. [
a]
D
ꢂ30.5 (c 1.18, CHCl3): 1H NMR (400 MHz, CDCl3)
d 7.90e7.76 (m,
3H), 7.76e7.64 (m, 1H), 7.54 (d, J¼8.2 Hz, 2H), 7.51e7.37 (m, 5H),
6.63e6.43 (m, 2H), 3.99e3.69 (m, 1H), 1.58 (d, J¼7.0 Hz, 3H); 13C
NMR (101 MHz, CDCl3)
d 142.5, 141.13, 141.11, 138.0, 133.8, 132.4,
129.0 (q, JCeF¼32.3 Hz), 128.3, 127.78, 127.76, 126.4, 126.3, 126.2,
125.64, 125.57 (q, JCeF¼4.0 Hz),125.5,124.4 (q, JCeF¼272.7 Hz), 42.8,
21.1; FTIR (NaCl/thin film) 3053, 2967, 1615, 1325, 1164, 1121,
1067 cmꢂ1; HRMS (EIþ) [M]þ calculated for C21H17F3: 326.1282,
found: 326.1284.
4.2.9. (S)-2-(1-p-Tolylethyl)naphthalene (10). General procedure
was followed using 10 mol % Ni(cod)2 and benzylic ammonium
triflate 1a prepared in 99.6% ee. The crude material was purified by
silica gel chromatography (100% hexanes) to give compound 10
(40 mg, 82%) as a white solid. The enantiomeric excess was de-
termined to be >99% ee by chiral HPLC analysis (CHIRALPAK IB,
4.2.6. (S,E)-2-(4-(4-Chlorophenyl)but-3-en-2-yl)naphthalene
(7). General procedure was followed using 3 mol % Ni(cod)2 and
benzylic ammonium triflate 1a prepared in 99.6% ee. The crude
material was purified by silica gel chromatography (100% hexanes)
to give 7 (44.0 mg, 76%) as a white solid (mp 68e71 ꢀC). The en-
antiomeric excess was determined to be 99% ee by chiral HPLC
0.4 mL/min, 100% hexane,
(400 MHz, CDCl3)
l
¼254 nm); tR (major)¼21.65: 1H NMR
d
7.86e7.66 (m, 4H), 7.52e7.36 (m, 2H), 7.31 (dd,
J¼8.4, 1.8 Hz, 1H), 7.21e7.06 (m, 4H), 4.29 (q, J¼7.2 Hz, 1H), 2.32 (s,
3H), 1.72 (d, J¼7.2 Hz, 3H); 13C NMR (101 MHz, CDCl3)
d 144.0, 143.3,
135.6,133.5,132.1,129.1,128.0,127.8,127.7,127.6,126.9,126.0,125.4,
125.3, 44.5, 21.9, 21.1. The spectral data for this compound matches
that reported in the literature.8 Comparison of the HPLC spectrum
of this product to that previously obtained in our laboratory con-
firmed that the absolute configuration of this product is S.8
analysis (CHIRALPAK IB, 1.0 mL/min, 100% hexane,
l
¼254 nm); tR
24
(major)¼22.47 min, tR (minor)¼28.85 min. [
a]
ꢂ40.8 (c 1.42,
D
CHCl3): 1H NMR (400 MHz, CDCl3)
d
7.98e7.82 (m, 3H), 7.77 (s, 1H),
7.63e7.43 (m, 3H), 7.43e7.25 (m, 4H), 6.59e6.38 (m, 2H), 3.98e3.80
(m, 1H), 1.63 (d, J¼7.0 Hz, 3H); 13C NMR (101 MHz, CDCl3)
d
13C NMR
4.2.10. (S)-2-(2-Methyl-1-p-tolylpropyl)naphthalene (12). General
procedure was followed using 10 mol % Ni(cod)2 and benzylic
ammonium triflate 1b prepared in >95% ee. The crude material was
purified by silica gel chromatography (100% hexanes) to give
compound 12 (30 mg, 55%) as a white solid (mp 77e78 ꢀC). The
enantiomeric excess was determined to be 86% ee by chiral HPLC
(101 MHz, CDCl3)
d 142.4, 141.0, 141.0, 137.9, 133.7, 132.3, 128.2,
127.69, 127.66, 126.3, 126.2, 126.1, 125.6, 125.4, 42.7, 21.0; 13C NMR
(101 MHz, (CD3)2CO) 143.8, 137.2, 136.8, 134.5, 133.1, 132.7, 129.2,
d
128.7, 128.4, 128.3, 128.2, 128.1, 126.9, 126.6, 126.1, 125.8, 43.4, 21.4;
FTIR (NaCl/thin film) 3052, 2965, 1490, 1091, 966 cmꢂ1; HRMS (EIþ)
[M]þ calculated for C20H17Cl: 292.1019, found: 292.0993. Please
note: Although two 13C NMR peaks are coincident when CDCl3 is
used as solvent, all 18 13C NMR peaks are seen when (CD3)2CO is
used as solvent.
analysis (CHIRALPAK IB, 0.8 mL/min, 100% hexane,
l
¼254 nm); tR
ꢂ33.5 (c 0.864,
7.85e7.61 (m, 4H), 7.49e7.31
24
(major)¼8.24 min, tR (minor)¼8.93 min. [
a]
D
CHCl3): 1H NMR (400 MHz, CDCl3)
d
(m, 3H), 7.31e7.16 (m, 2H), 7.05 (d, J¼7.8 Hz, 2H), 3.53 (d, J¼10.8 Hz,
1H), 2.67e2.47 (m, 1H), 2.25 (s, 3H), 0.91 (d, J¼6.4 Hz, 3H), 0.87 (d,
4.2.7. (S,E)-2-(4-(4-Methoxyphenyl)but-3-en-2-yl)naphthalene
(8). General procedure was followed using 3 mol % Ni(cod)2 and
benzylic ammonium triflate 1a prepared in 99.6% ee. The crude
material was purified by silica gel chromatography (100% hexanes)
to give compound 8 (53.0 mg, 91%) as a white solid (mp 78e80 ꢀC).
The enantiomeric excess was determined to be 99% ee by chiral
J¼6.4 Hz, 3H); 13C NMR (101 MHz, CDCl3)
d 142.7, 141.7, 135.5, 133.6,
132.1, 129.1, 128.0, 127.9, 127.6, 127.5, 126.5, 126.2, 125.8, 125.1, 60.5,
31.6, 22.0, 21.9, 21.0; FTIR (NaCl/thin film) 3053, 3019, 2955, 2922,
2868, 1508, 1457, 1385, 813, 760, 741 cmꢂ1; HRMS (EIþ) [M]þ cal-
culated for C21H22: 274.1722, found: 274.1724.
HPLC analysis (CHIRALPAK IA, 0.6 mL/min, 1% EtOAc/hexane,
4.2.11. (S)-2-(Phenyl(p-tolyl)methyl)naphthalene (13). General pro-
cedure was followed using 10 mol % Ni(cod)2 and benzylic am-
monium triflate 1c prepared in >95% ee. The crude material was
purified by silica gel chromatography (100% hexanes) to give
compound 13 (36 mg, 58%) as an oil. The enantiomeric excess was
determined to be 52% ee by chiral HPLC analysis (CHIRALCEL OD-H,
24
l
¼254 nm); tR (major)¼27.88 min, tR (minor)¼30.19 min. [
a]
D
ꢂ35.7 (c 1.43, CHCl3): 1H NMR (400 MHz, CDCl3)
d 7.86e7.77 (m,
3H), 7.72e7.68 (m, 1H), 7.50e7.38 (m, 3H), 7.34e7.28 (m, 2H),
6.90e6.80 (m, 2H), 6.48e6.26 (m, 2H), 3.81e3.78 (m, 4H), 1.55 (d,
J¼7.2 Hz, 3H); 13C NMR (101 MHz, CDCl3)
d 158.9, 143.4, 133.7, 133.1,
132.3, 130.4, 128.3, 128.1, 127.8, 127.7, 127.4, 126.5, 126.0, 125.4,
125.3, 114.0, 55.4, 42.7, 21.4; FTIR (NaCl/thin film) 2962, 1607, 1511,
1250, 1175, 1034 cmꢂ1; HRMS (EIþ) [M]þ calculated for C21H20O:
288.1514, found: 288.1517.
0.3 mL/min, 0.2% i-PrOH/pentane,
l
¼254 nm); tR (major)¼
24
38.59 min, tR (minor)¼40.72 min. [
a
]
D
þ37.6 (c 1.88, CHCl3): 1H
NMR (400 MHz, CDCl3)
d
7.95e7.71 (m, 3H), 7.54 (s, 1H), 7.49 (dt,
J¼6.1, 3.5 Hz, 2H), 7.40e7.33 (m, 3H), 7.33e7.26 (m, 1H), 7.26e7.20
(m, 2H), 7.20e7.09 (m, 4H), 5.74 (s, 1H), 2.40 (s, 3H); 13C NMR
4.2.8. (R)-2-(3-Phenylbut-3-en-2-yl)naphthalene (9). General pro-
cedure was followed using 3 mol % Ni(cod)2 and benzylic ammo-
nium triflate 1a prepared in 99.6% ee. The crude material was
purified by silica gel chromatography (100% hexane) to give com-
pound 9 (26 mg, 50%) as a white solid (mp 64e65 ꢀC). The enan-
tiomeric excess was determined to be 96% ee by chiral HPLC
analysis (CHIRALCEL OD-H, 0.8 mL/min, 1% i-PrOH/hexane,
(101 MHz, CDCl3) d 143.9, 141.7, 140.7, 135.9, 133.4, 132.1, 129.5,
129.4,129.1,128.3,128.1,127.9, 127.8, 127.7,127.5,126.3,125.9,125.6,
56.5, 21.1. The spectral data for this compound matches that re-
ported in the literature.5c
4.2.12. (R)-2-(1-(4-Fluorophenyl)ethyl)naphthalene (14). General
procedure was followed using 10 mol % Ni(cod)2 and benzylic